AC Immune (AC Immune) Accounts Payable : $3.19 Mil (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is AC Immune Accounts Payable?

AC Immune's Accounts Payable for the quarter that ended in Mar. 2024 was $3.19 Mil.

AC Immune's quarterly Accounts Payable increased from Sep. 2023 ($1.64 Mil) to Dec. 2023 ($1.94 Mil) and increased from Dec. 2023 ($1.94 Mil) to Mar. 2024 ($3.19 Mil).

AC Immune's annual Accounts Payable declined from Dec. 2021 ($2.18 Mil) to Dec. 2022 ($1.00 Mil) but then increased from Dec. 2022 ($1.00 Mil) to Dec. 2023 ($1.94 Mil).

AC Immune Accounts Payable Historical Data

The historical data trend for AC Immune's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AC Immune Accounts Payable Chart

AC Immune Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable

Get a 7-Day Free Trial

0.15

2.46

2.18

1.00

1.94

AC Immune Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable	Get a 7-Day Free Trial															1.23	1.50	1.64	1.94	3.19

AC Immune Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

AC Immune Accounts Payable Related Terms

Thank you for viewing the detailed overview of AC Immune's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

AC Immune (AC Immune) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AC Immune SA (NAS:ACIU) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

IMR:Germany IMR:Germany

Address

EPFL Innovation Park, Building B, Lausanne, CHE, 1015

Website

https://www.acimmune.com

AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding.